Dr. Hohl began his career at the University of Iowa, College of Medicine in 1991, where he served as assistant professor in the department of internal medicine. He became an assistant professor in the department of pharmacology in 1993 and was promoted to associate professor of both internal medicine and pharmacology in 1997. Dr. Hohl became the director of the division of hematology, oncology and blood and marrow transplantation at the Roy J. and Lucille A. Carver College of Medicine, University of Iowa in 1995. In 1999, he became the associate director for clinical research clinical research: A type of research that involves individual persons or a group of people. There are three types of clinical research. Patient-oriented research includes clinical trials which test how a drug, medical device, or treatment approach works in people. Epidemiology or behavioral studies look at the… for the Holden Comprehensive Cancer Center at The University of Iowa. Dr. Hohl was named the director of the fellowship program, division of hematology, oncology and blood and marrow transplantation department of internal medicine at the Roy J. and Lucille A. Carver College of Medicine, University of Iowa in 2000. He was promoted to professor of both internal medicine and pharmacology in 2002 and named associate chair to the department of internal medicine in 2005. At that time he was also named associate director for clinical translational research for the Holden Comprehensive Cancer Center at The University of Iowa. In 2013, Dr. Hohl was named director of the Penn State Cancer Institute, professor of medicine and pharmacology at the Penn State College of Medicine, Penn State University, and holds the university professorship in medicine. Dr. Hohl is a medical oncologist oncologist: (on-KAH-luh-jist) A doctor who specializes in the treatment and prevention of cancer. , hematologist hematologist: (hee-muh-TOL-uh-jist) A doctor who specializes in treating blood diseases and disorders of blood producing organs. and clinical pharmacologist and has broad experience as a clinical and translational researcher.
Penn State Cancer Institute
400 University Dr
Hershey, PA 17033
United States
